微信公众号

官网二维码

中国癌症防治杂志 ›› 2020, Vol. 12 ›› Issue (1): 69-74.doi: 10.3969/j.issn.1674-5671.2020.01.12

• 临床研究 • 上一篇    下一篇

胃癌No.14v组淋巴结转移的危险因素及预后分析

  

  1. 广西医科大学第一附属医院胃肠腺体外科
  • 出版日期:2020-02-25 发布日期:2020-03-10
  • 通讯作者: 陈俊强 E-mail:gxhans@163.com
  • 基金资助:
    广西科技计划重点研发项目(桂科AB18126058);广西自然科学基金项目(2016GXNSFAA380180);广西卫生和计划生育委员会自筹经费科研课题(Z2015526);广西医科大学青年科学基金项目(GXMUYSF201502)  

Risk factors and prognostic analysis of lymph node metastasis in No.14v group in gastric cancer

  • Online:2020-02-25 Published:2020-03-10
  • Supported by:
     

摘要: 目的 探讨胃癌No.14v组淋巴结转移的危险因素及对预后的影响。方法 回顾性分析72例行胃癌D2根治术+No.14v组淋巴结清扫患者的临床资料。采用Logistic回归分析影响No.14v组淋巴结转移的因素,Cox回归分析No.14v组淋巴结转移与预后的关系。结果 No.14v组淋巴结转移率为25.0%(18/72)。Logistic回归分析显示,Borromann分型Ⅲ~Ⅳ型(OR=81.508,95%CI:4.805~1 382.635,P=0.002)、远处转移(OR=11.494,95%CI:1.085~121.723,P=0.043)和TNM分期Ⅲ~Ⅳ期(OR=8.101,95%CI:1.355~48.437,P=0.005)是影响No.14v组淋巴结转移的独立危险因素。No.14v组淋巴结转移组患者的中位生存时间低于非转移组(22个月 vs 33 个月,χ2=22.737,P<0.001);多因素Cox回归分析显示,No.14v组淋巴结转移是影响患者总生存期的独立影响因素(HR=2.881,95%CI:1.222~6.793,P=0.016)。 结论 No.14v组淋巴结转移的胃癌患者预后较差,Borromann分型Ⅲ~Ⅳ型、远处转移及TNM分期Ⅲ~Ⅳ期是No.14v组淋巴结转移的独立危险因素。

关键词: 胃癌, No.14v组淋巴结, 危险因素, 预后

Abstract: Objective To investigate the risk factors and to perform prognostic analysis of lymph node metastasis in the No.14v group in gastric cancer. Methods The clinical data of 72 gastric cancer patients who underwent radical gastrectomy with lymph node in the No.14v group dissection were analyzed retrospectively. Logistic regression was used to analyze the factors affecting lymph node metastasis in the No.14v group,Cox regression was used to analyze the relationship between lymph node metastasis in the No.14v group and prognosis. Results The lymph node metastasis rate in the No.14v group was 25.0%(18/72). Logistic regression analysis showed that Borromann classification Ⅲ-Ⅳ(OR=81.508,95%CI:4.805-1 382.635,P=0.002),distant metastasis(OR=11.494,95%CI:1.085-121.723,P=0.043),and TNM stages Ⅲ-Ⅳ(OR=8.101,95%CI:1.355-48.437,P=0.005) were independent risk factors affecting lymph node metastasis in the No.14v group. The median overall survival of patients with lymph node metastasis in the No.14v group was lower than that in the non-metastatic group(22 months vs 33 months,χ2= 22.737,P<0.001). Multivariate Cox regression analysis showed that lymph node metastasis in the No.14v group was an independent influencing factor for the overall survival of patients(HR=2.881, 95%CI:1.222-6.793,P=0.016). Conclusions Patients with lymph node metastasis in the No.14v group have a poor prognosis in gastric cancer,and the independent risk factors for lymph node metastasis in the No.14v group include Borromann classification Ⅲ-Ⅳ,distant metastasis,and TNM stage Ⅲ-Ⅳ.

Key words: Gastric cancer, No.14v lymph node, Risk factors, Prognosis

中图分类号: 

  • R735.2